Alderley Analytical Ltd
08665244
Healthy
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 18/04/2026
Due 02/05/2027
Industry
Officers
Persons with Significant Control
Synexa Life Sciences Ltd
1st Floor Arthur Stanley House, 40-50 Tottenham Street, London, W1T 4RN
Reg: 08249730 · Companies House · Private Limited Company
Notified 02/10/2024
Charges1 outstanding
ALTER DOMUS TRUSTEES (UK) LIMITED
NPIF NW DEBT LP ACTING BY NORTH WEST LOANS NPIF GP LIMITED AS THE GENERAL PARTNER OF NPIF NW DE
NPIF NW DEBT LP ACTING BY NORTH WEST LOANS NPIF GP LIMITED AS THE GENERAL PARTNER OF NPIF NW DE
NPIF NW DEBT LP ACTING BY NORTH WEST LOANS NPIF GP LIMITED AS THE GENERAL PARTNER OF NPIF NW DE
ELIZABETH THOMAS AS SECURITY TRUSTEE FOR THE SECURITY BENEFICIARIES
CompanyRankvs 801+ SIC 72110 peers61
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£284k
Balance sheet strength
Cash
£254k
Cash in the bank
Net Current Assets
-£489k
Working capital
Current Assets
£826k
Current Liabilities
£1.3M
Fixed Assets
£1.2M
Debtors
£545k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.63 | -£638k |
| 2023 | 1.18 | -£40k |
| 2021 | 1.93 | +£201k |
| 2020 | 2.57 | +£134k |
| 2019 | 1.66 | +£167k |
| 2018 | 1.50 | — |
Derived from filed accounts. Not audited figures.